日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity.

利用亚克隆反应异质性来定义癌症类器官的治疗敏感性

Kratz Jeremy D, Rehman Shujah, Johnson Katherine A, Gillette Amani A, Sunil Aishwarya, Favreau Peter F, Pasch Cheri A, Miller Devon, Zarling Lucas C, Yeung Austin H, Clipson Linda, Anderson Samantha J, Steimle Alyssa K, Sprackling Carley M, Lemmon Kayla K, Abbott Daniel E, Burkard Mark E, Bassetti Michael F, Eickhoff Jens C, Foley Eugene F, Heise Charles P, Kimple Randall J, Lawson Elise H, LoConte Noelle K, Lubner Sam J, Mulkerin Daniel L, Matkowskyj Kristina A, Sanger Cristina B, Uboha Nataliya V, Mcilwain Sean J, Ong Irene M, Carchman Evie H, Skala Melissa C, Deming Dustin A

Microwave ablation for colorectal cancer metastasis to the liver: a single-center retrospective analysis

微波消融治疗结直肠癌肝转移:单中心回顾性分析

Knott, Emily A; Ziemlewicz, Timothy J; Lubner, Sam J; Swietlik, John F; Weber, Sharon M; Zlevor, Annie M; Longhurst, Colin; Hinshaw, J Louis; Lubner, Meghan G; Mulkerin, Daniel L; Abbott, Daniel E; Deming, Dustin; LoConte, Noelle K; Uboha, Nataliya; Couillard, Allison B; Wells, Shane A; Laeseke, Paul F; Alexander, Marci L; Lee, Fred T Jr

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

一线化疗联合西妥昔单抗或贝伐珠单抗对KRAS野生型晚期或转移性结直肠癌患者总生存期的影响:一项随机临床试验

Venook, Alan P; Niedzwiecki, Donna; Lenz, Heinz-Josef; Innocenti, Federico; Fruth, Briant; Meyerhardt, Jeffrey A; Schrag, Deborah; Greene, Claire; O'Neil, Bert H; Atkins, James Norman; Berry, Scott; Polite, Blase N; O'Reilly, Eileen M; Goldberg, Richard M; Hochster, Howard S; Schilsky, Richard L; Bertagnolli, Monica M; El-Khoueiry, Anthony B; Watson, Peter; Benson, Al B 3rd; Mulkerin, Daniel L; Mayer, Robert J; Blanke, Charles

A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors

组蛋白去乙酰化酶抑制剂帕比司他治疗低级别神经内分泌肿瘤患者的II期临床试验

Jin, Ning; Lubner, Sam J; Mulkerin, Daniel L; Rajguru, Saurabh; Carmichael, Lakeesha; Chen, Herb; Holen, Kyle D; LoConte, Noelle K

A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer

一项针对难治性实体瘤和KRAS突变型结直肠癌的selumetinib(AZD6244/ARRY-142866,一种MEK1/2抑制剂)联合西妥昔单抗的I期研究

Deming, Dustin A; Cavalcante, Ludmila L; Lubner, Sam J; Mulkerin, Daniel L; LoConte, Noelle K; Eickhoff, Jens C; Kolesar, Jill M; Fioravanti, Suzanne; Greten, Tim F; Compton, Kathryn; Doyle, Austin G; Wilding, George; Duffy, Austin; Liu, Glenn

Multidisciplinary Optimization of Oral Chemotherapy Delivery at the University of Wisconsin Carbone Cancer Center

威斯康星大学卡本癌症中心口服化疗药物输送的多学科优化

Mulkerin, Daniel L; Bergsbaken, Jason J; Fischer, Jessica A; Mulkerin, Mary J; Bohler, Aaron M; Mably, Mary S

Precision medicine in colorectal cancer: the molecular profile alters treatment strategies

结直肠癌精准医疗:分子特征改变治疗策略

Tran, Nguyen H; Cavalcante, Ludimila L; Lubner, Sam J; Mulkerin, Daniel L; LoConte, Noelle K; Clipson, Linda; Matkowskyj, Kristina A; Deming, Dustin A

A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors

一项针对难治性实体瘤的γ-分泌酶抑制剂RO4929097联合卡培他滨的多中心I期研究

LoConte, Noelle K; Razak, Albiruni R A; Ivy, Percy; Tevaarwerk, Amye; Leverence, Rachael; Kolesar, Jill; Siu, Lillian; Lubner, Sam J; Mulkerin, Daniel L; Schelman, William R; Deming, Dustin A; Holen, Kyle D; Carmichael, Lakeesha; Eickhoff, Jens; Liu, Glenn

A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study

一项针对晚期胰腺癌和胆道癌患者的索拉非尼、奥沙利铂和2天高剂量卡培他滨I期研究:威斯康星肿瘤网络研究

LoConte, Noelle K; Holen, Kyle D; Schelman, William R; Mulkerin, Daniel L; Deming, Dustin A; Hernan, Hilary R; Traynor, Anne M; Goggins, Timothy; Groteluschen, David; Oettel, Kurt; Robinson, Emily; Lubner, Sam J

A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer

奥沙利铂、5-氟尿嘧啶、亚叶酸钙和高剂量卡培他滨治疗转移性结直肠癌患者的II期研究

Lubner, Sam J; Loconte, Noelle K; Holen, Kyle D; Schelman, William; Thomas, James P; Jumonville, Alcee; Eickhoff, Jens C; Seo, Songwon; Mulkerin, Daniel L